Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/7/2025

Naltrexone for Trichotillomania Treatment

Monitoring and Safety

  • Baseline liver function tests are mandatory, with repeat testing every 3-6 months due to potential hepatotoxicity at therapeutic doses, as recommended by clinical guidelines 1
  • Assess for contraindications including acute hepatitis, liver failure, or concurrent need for opioid analgesics, according to clinical guidelines 1

Side Effects and Considerations

  • Common side effects of naltrexone include headache, tachycardia, vivid dreams, nausea, and gastrointestinal symptoms 1, 2
  • Hepatotoxicity can occur at supratherapeutic doses, emphasizing the need for careful monitoring 1

Treatment Considerations

  • Naltrexone may be considered for patients who have failed or cannot tolerate N-acetylcysteine, or when comorbid conditions may benefit from opioid antagonism 1
  • Patient preference should be discussed after reviewing the limited evidence base for naltrexone in trichotillomania treatment 3
  • The established safety profile of naltrexone from its use in alcohol and opioid dependence is a consideration in its use for trichotillomania 3, 4